Proto Labs
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 weeks.
- Recent price momentum is -2.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation C-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 39.9x | Better than 13% |
| Forward P/E | 34.1x | Better than 14% |
| Price / Sales | 2.8x | Better than 45% |
| P/E vs own 5-yr range | 58th pctl | Better than 52% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 3.0% | Better than 38% |
| Net income CAGR (3Y) | -20.8% | Better than 17% |
| Free cash flow CAGR (3Y) | 13.9% | Better than 58% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 44.5% | Better than 55% |
| Operating margin | 4.9% | Better than 34% |
| Net margin | 4.0% | Better than 40% |
| Return on equity | 3.2% | Better than 33% |
| Return on invested capital | 3.1% | Better than 38% |
Momentum C+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -27.7% | Better than 20% |
| 6-month return | -19.4% | Better than 28% |
| 12-month return (ex latest month) | 75.3% | Better than 91% |
| Distance below 52-week high | 42.5% | Better than 26% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.5x | Better than 78% |
| Debt to assets | 0.4% | Better than 96% |
| Free cash flow / net income | 280.9% | Better than 85% |
Analyst View N/A
What the Street thinks: share of Buy ratings and upside to the average target.
Not enough data to grade this factor.
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 62.89
- Open
- 61.74
- Day range
- 56.88 - 62.49
- Avg price
- 58.55
- Volume
- 343.50K
- Turnover
- 20.11M
- Turnover ratei
- 1.46%
- Volume ratioi
- 1.55
- Amplitudei
- 8.92%
- 52-week rangei
- 48.71 - 99.96
Valuation
- P/Ei
- 65.36
- P/E (TTM)i
- 39.94
- P/Bi
- 1.96
- EPSi
- 0.88
- Book value / shi
- 29.40
- Net profit
- 21.01M
- Net assets
- 701.81M
Share structure
- Market cap
- 1.37B
- Float capi
- 1.36B
- Shares out
- 23.87M
- Float sharesi
- 23.60M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
42.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-4.77M net over the window
Short interest
- Shares short
- 616.29K
- % of floati
- 2.58%
- Days to coveri
- 2.41
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Proto Labs (PRLB)?
Proto Labs last traded at 57.52. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Proto Labs's market cap?
About 1.37B.
What is the P/E ratio of Proto Labs?
The trailing twelve-month P/E is 39.94, below its own 5-year average of 41.50 — in the middle of its historical range (57.58% percentile). See the Valuation tab for the full history.
Does Proto Labs pay a dividend?
Proto Labs does not currently pay a regular dividend.
Is Proto Labs a buy according to analysts?
The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 110.00, which implies 91.2% upside from the current price. This is not investment advice.
What is Proto Labs's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Proto Labs a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Proto Labs discussion 0 comments